Why Did Cooper Companies (COO) Move Today?

Activist pressure collides with recent board decisions at Cooper Companies

Cooper Companies (COO) is back in focus after activist investor Jana Partners publicly urged the board to launch an external CEO search, install a new chair, and consider asset sales.

The call comes only days after directors finished a wide ranging review that looked at portfolio options, capital allocation, structure, and leadership, and chose to keep CooperSurgical rather than pursue a sale.

Cooper Companies shares have picked up slightly in the last week, with a 1-day share price return of 2.82% and 7-day gain of 2.56%. However, the 30-day share price return is down 27.46% and the 1-year total shareholder return is lower by 18.89% as investors react to weaker recent guidance, the completed buyback program and now fresh activist pressure on the board.

Compare Cooper Companies' situation with other businesses under fresh investor scrutiny by scanning our hand picked 30 resilient stocks with low risk scores, which pair resilient financial profiles with tighter risk controls.

Cooper Companies now trades well below both analyst targets and an indicated intrinsic value after a sharp guidance cut and activist noise. Is that gap mispricing, or is the market simply respecting the risks?

Most Popular Narrative: 18% Undervalued

The most followed narrative on Cooper Companies pegs fair value at $67.43 per share, compared with the latest close near $55. That gap rests on a view that current headwinds are temporary while cash generation and buybacks build value in the background.

Free cash flow is poised to inflect higher as a multi-year capital expenditure cycle winds down following the ramp-up of MyDAY capacity. Management is guiding for approximately $2 billion in free cash flow over the next three years. This improved cash generation, tied to strong cost discipline and revenue momentum, will further benefit shareholders via debt reduction and share repurchases.

See why 17 investors see Cooper Companies as 18% undervalued.

Result: Fair Value of $67.43 (UNDERVALUED)

Still, two things could easily upset the Cooper Companies recovery story: slower contact lens market growth and ongoing weakness in CooperSurgical fertility and Paragard activity.

Find out about the key risks to this Cooper Companies narrative.

Next Steps

Sentiment on Cooper Companies is clearly split, so treat that as a signal to move quickly with your own research and carefully stress test the case for those 4 key rewards.

Looking for more investment ideas beyond Cooper Companies?

If Cooper Companies has sharpened your focus, broaden your watchlist with a few targeted screens that can surface fresh names before the wider market pays attention.

• Target higher income potential by reviewing steady payers in the 7 dividend fortresses that could help anchor your portfolio with sizeable yields.
• Hunt for mispriced quality using the 35 high quality undervalued stocks to spot businesses where fundamentals and market pricing appear out of step.
• Secure a stronger foundation by scanning the list of solid balance sheet and fundamentals (23 results) and focus on companies built on healthier balance sheets and resilient cash generation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com